Autolus Therapeutics announces the appointment of Mike Bonney as Chairman of the Board, and Ravi Rao M.D., as Non-Executive Director. John Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director. Bonney served as CEO and Director of Cubist Pharmaceuticals from 2003 until 2014. Rao currently serves as Chief Medical Officer of Sitryx, having joined the company in 2022
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AUTL:
- Autolus Therapeutics Announces Changes to its Board of Directors
- Autolus files to sell 33.33M American Depositary Shares for holders
- Aveo Oncology appoints Edgar Braendle as CMO
- Autolus Therapeutics price target raised to $10 from $9 at Truist
- Autolus Therapeutics Announces Annual Results and CDO Resignation
